An in silico simulation of the frequency of administering <scp>HLA</scp>‐incompatible low titer group O whole blood units when the donor pool includes unscreened female donors

Blood collectors and hospitals should evaluate the potential TRALI risk against the benefit of a potentially expanded inventory of LTOWB before collecting plasma-containing products from non-HLA-tested parous female donors.